{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:16:46Z","timestamp":1790482606577,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,27]],"date-time":"2027-07-27T00:00:00Z","timestamp":1816646400000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K08 AI163462"],"award-info":[{"award-number":["K08 AI163462"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajt.2026.03.017","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:38:52Z","timestamp":1774514332000},"page":"1991-2003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Organ-specific differences in the epidemiology of cytomegalovirus infections in high-risk (cytomegalovirus donor seropositive, recipient seronegative) solid organ transplant recipients with prolonged follow-up: A 10-year experience"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9424-1870","authenticated-orcid":false,"given":"Madeleine R.","family":"Heldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-9605","authenticated-orcid":false,"given":"Eileen K.","family":"Maziarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-431X","authenticated-orcid":false,"given":"Jennifer L.","family":"Saullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4602-1889","authenticated-orcid":false,"given":"Patrick C.K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2430-7560","authenticated-orcid":false,"given":"Sonya","family":"Kothadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7140-9096","authenticated-orcid":false,"given":"Sana","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0771-3647","authenticated-orcid":false,"given":"Julie M.","family":"Steinbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1845-4476","authenticated-orcid":false,"given":"Beatrice Z.","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9529-036X","authenticated-orcid":false,"given":"Jonathan P.","family":"Huggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5365-5030","authenticated-orcid":false,"given":"Cameron R.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Seidenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5170-8627","authenticated-orcid":false,"given":"Matthew J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4780-4156","authenticated-orcid":false,"given":"Goni","family":"Katz-Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay Y.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5496-0590","authenticated-orcid":false,"given":"Jacqueline B.","family":"Henson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2366-2579","authenticated-orcid":false,"given":"Lisa M.","family":"McElory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4679-2221","authenticated-orcid":false,"given":"Adam D.","family":"DeVore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1522-0308","authenticated-orcid":false,"given":"Joseph B.","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-3129","authenticated-orcid":false,"given":"Jennifer","family":"Byrns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7369-7687","authenticated-orcid":false,"given":"Matt T.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5868-0529","authenticated-orcid":false,"given":"Barbara D.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0914-0291","authenticated-orcid":false,"given":"Arthur W.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajt.2026.03.017_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cid\/ciae535","article-title":"Current and future strategies for the prevention and treatment of cytomegalovirus infections in transplantation","volume":"81","author":"Heldman","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ajt.2026.03.017_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ajt.2026.03.017_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2023.9106","article-title":"Letermovir vs valganciclovir for prophylaxis of cytomegalovirus in high-risk kidney transplant recipients: a randomized clinical trial","volume":"330","author":"Limaye","year":"2023","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.ajt.2026.03.017_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/jama.2020.3138","article-title":"Effect of preemptive therapy vs antiviral prophylaxis on cytomegalovirus disease in seronegative liver transplant recipients with seropositive donors: a randomized clinical trial","volume":"323","author":"Singh","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ajt.2026.03.017_bib5","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in D+\/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2026.03.017_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2023.100047","article-title":"Cytomegalovirus infection in heart transplant recipients: epidemiology, risk factors, and long-term outcomes from a major transplant center in the United States","volume":"4","author":"Bisono-Garcia","year":"2024","journal-title":"JHLT Open"},{"issue":"9","key":"10.1016\/j.ajt.2026.03.017_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15453","article-title":"Cytomegalovirus post-prophylaxis surveillance in high-risk kidney and liver recipients prevents CMV end-organ disease and ganciclovir-resistance","volume":"38","author":"Jorgenson","year":"2024","journal-title":"Clin Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2026.03.017_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70015","article-title":"Survey of post-prophylaxis delayed-onset cytomegalovirus management strategies among transplant providers","volume":"38","author":"Non","year":"2024","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.03.017_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14292","article-title":"Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: does recurrent cytomegalovirus DNAemia impact patient survival?","volume":"26","author":"Fern\u00e1ndez-Garc\u00eda","year":"2024","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.ajt.2026.03.017_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/TP.0b013e318200b9f0","article-title":"Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients","volume":"91","author":"Boillat Blanco","year":"2011","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.ajt.2026.03.017_bib11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/TP.0b013e31822fa4b7","article-title":"Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients","volume":"92","author":"Lisboa","year":"2011","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.ajt.2026.03.017_bib12","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/j.1600-6143.2010.03225.x","article-title":"Primary CMV infections are common in kidney transplant recipients after 6 months valganciclovir prophylaxis","volume":"10","author":"Helanter\u00e4","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.03.017_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1399-3062.2011.00624.x","article-title":"Risk factors for late-onset cytomegalovirus disease in donor seropositive\/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis","volume":"13","author":"Boudreault","year":"2011","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.ajt.2026.03.017_bib14","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.03.017_bib15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2026.03.017_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-152-12-201006150-00003","article-title":"Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial","volume":"152","author":"Palmer","year":"2010","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ajt.2026.03.017_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70073","article-title":"Contemporary cytomegalovirus (CMV) infections in low-risk CMV seronegative recipients of solid organ transplants from CMV seronegative donors (D-\/R-): time to reexamine donor CMV serostatus","volume":"39","author":"Heldman","year":"2025","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.03.017_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/ciae321","article-title":"Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory CMV for use in clinical trials: 2024 update from the transplant associated virus infections forum","volume":"79","author":"Ljungman","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ajt.2026.03.017_bib20","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1111\/ajt.16066","article-title":"Transfusion-transmitted and community-acquired cytomegalovirus infection in seronegative solid organ transplant recipients receiving seronegative donor organs","volume":"20","author":"Mabilangan","year":"2020","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2026.03.017_bib21","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1111\/ajt.16734","article-title":"Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti-viral prophylaxis at play?","volume":"21","author":"Hernandez","year":"2021","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2026.03.017_bib22","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","article-title":"Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy","volume":"12","author":"Atabani","year":"2012","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.03.017_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/jiab132","article-title":"Unexpected cytomegalovirus (CMV) replication kinetics in CMV donor-seropositive, recipient-seronegative liver transplant recipients receiving preemptive antiviral therapy","volume":"225","author":"Singh","year":"2022","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.ajt.2026.03.017_bib24","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/01.TP.0000142619.01510.A5","article-title":"Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients","volume":"78","author":"Freeman","year":"2004","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ajt.2026.03.017_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13581","article-title":"Examining valganciclovir prophylaxis duration among high-risk donor seropositive\/recipient seronegative heart transplant recipients in a larger cohort","volume":"23","author":"Imlay","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1016\/j.ajt.2026.03.017_bib26","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1016\/j.transproceed.2013.08.023","article-title":"Low-dose valganciclovir for cytomegalovirus prophylaxis in heart transplant recipients","volume":"45","author":"Julian","year":"2013","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.ajt.2026.03.017_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.healun.2025.08.023","article-title":"Tolerability and clinical efficacy of letermovir for primary cytomegalovirus prophylaxis after heart transplantation","volume":"45","author":"Chow","year":"2026","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2026.03.017_bib28","doi-asserted-by":"crossref","DOI":"10.4212\/cjhp.3701","article-title":"Risk of cytomegalovirus infection after 3 or 6 months of valganciclovir prophylaxis among donor-seropositive, recipient-seronegative heart transplant recipients","volume":"78","author":"Leclerc","year":"2025","journal-title":"Can J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.ajt.2026.03.017_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14227","article-title":"Incidence of valganciclovir-related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease","volume":"26","author":"Belga","year":"2024","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.ajt.2026.03.017_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/cid\/ciab574","article-title":"Immunoguided discontinuation of prophylaxis for cytomegalovirus disease in kidney transplant recipients treated with antithymocyte globulin: a randomized clinical trial","volume":"74","author":"P\u00e1ez-Vega","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2 M7","key":"10.1016\/j.ajt.2026.03.017_bib31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/1874303X01407010152","article-title":"Efficacy of extended valganciclovir prophylaxis in preventing cytomegalovirus infection in pediatric kidney transplantation","volume":"7","author":"Hashim","year":"2014","journal-title":"Open Urol Nephrol J"},{"key":"10.1016\/j.ajt.2026.03.017_bib32","article-title":"Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3, noninferiority trial","volume":"52","author":"P\u00e1ez-Vega","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.ajt.2026.03.017_bib33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1055\/s-0039-1688443","article-title":"Immunosuppressive drug levels in liver transplant recipients: impact in decision making","volume":"39","author":"Kourkoumpetis","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.ajt.2026.03.017_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13255","article-title":"Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high-risk donor seropositive\/recipient seronegative heart transplant recipients","volume":"22","author":"Imlay","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"10.1016\/j.ajt.2026.03.017_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70223","article-title":"Comparison of short versus extended valganciclovir prophylaxis in donor-positive recipient-negative mismatched heart transplant recipients: an observational study","volume":"39","author":"Miller","year":"2025","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2026.03.017_bib36","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/lt.26045","article-title":"Association of donor and recipient cytomegalovirus serostatus on graft and patient survival in liver transplant recipients","volume":"27","author":"Vutien","year":"2021","journal-title":"Liver Transpl"},{"issue":"18","key":"10.1016\/j.ajt.2026.03.017_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180115","article-title":"Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis","volume":"9","author":"Zamora","year":"2024","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.ajt.2026.03.017_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001514","article-title":"A systematic review and meta-analysis of optimized CMV preemptive therapy and antiviral prophylaxis for CMV disease prevention in CMV high-Risk (D+R\u2212) kidney transplant recipients","volume":"9","author":"Kumar","year":"2023","journal-title":"Transplant Direct"},{"issue":"10","key":"10.1016\/j.ajt.2026.03.017_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15065","article-title":"Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation","volume":"37","author":"Lerman","year":"2023","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.03.017_bib40","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1097\/TP.0000000000003015","article-title":"The association between cytomegalovirus infection and cardiac allograft vasculopathy in the era of antiviral valganciclovir prophylaxis","volume":"104","author":"Klimczak-Tomaniak","year":"2020","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.ajt.2026.03.017_bib41","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/tri.13155","article-title":"Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era - a retrospective study","volume":"31","author":"Goekler","year":"2018","journal-title":"Transpl Int"},{"issue":"8","key":"10.1016\/j.ajt.2026.03.017_bib42","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.healun.2015.03.015","article-title":"Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation","volume":"34","author":"Delgado","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.03.017_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI182317","article-title":"A vaccine against cytomegalovirus: how close are we?","volume":"135","author":"Permar","year":"2025","journal-title":"J Clin Invest"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352600167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352600167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:54:21Z","timestamp":1786481661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352600167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S160061352600167X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2026.03.017","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organ-specific differences in the epidemiology of cytomegalovirus infections in high-risk (cytomegalovirus donor seropositive, recipient seronegative) solid organ transplant recipients with prolonged follow-up: A 10-year experience","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2026.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}